AI guided early detection of Alzheimer's and Parkinson's


At Philyra we couple scientific research with machine learning expertise to provide on site risk assessment

Find Out More

Early diagnosis of neurodegenerative diseases
is urgently needed


The current tests for AD and PD detection are costly, time consuming and focused on late stages of the disease. Philyra uses AI to design non invasive and real time tests that focuse on early symptoms and olfactory performance, speeding up diagnosis and cutting medical costs.

How it works


Insert your data on our app


Our test presents questions on your olfactory abilities and early symptoms. Thanks to the easy-to-use and inclusive interface of our app, patients can upload data by themselves or with the help of a nurse. We take care of data format and ensure data privacy

Our algorithm performs predictions

Using accurate machine learning algorithms, we identify patterns that are central to the classification of patients at risk

Real Time Diagnosis


We compute risk assessments (low, medium, high) for Alzheimer's and Parkinson's and based on the results, physicians give recommendations on further steps

Are you a medical professional or are you concerned for your relative developing dementia?
Join our waitlist and get early access to our test!

Our Team


Meet Our Experts

Dr Micol de Ruvo

Co-Founder

Masters in Biomedical Engineering and PhD in Computational Biology, with extensive experience in using algorithms to solve challenges in life science

Kai Lammel

Co-Founder

Several years of experience in product development and marketing in big corporates and commercial co-founder of a med-tech company

Backed by


Let's get in touch!

Ready to collaborate with us or curious to know more about Philyra?
Drop us a message, we will contact you the earliest